Two wild‐type MET‐overexpressing human cancer cell lines, gastric adenocarcinoma cell line GTL‐16, and the nonsmall cell lung cancer line EBC‐1 (Smolen et al., 2006) were first treated for 16 h with the specific MET inhibitor EMD1214063 (termed METi hereforth), IR (at a single dose of 10 Gy), or the combination, and were harvested at two time points (10 min and 8 h). This evidence concerns the gene MET and cancer.